Details
Our company’s Abidol Hydrochloride Tablets have been approved for market launch.
Release time:
2025-04-24 14:16
Source:
This product was initiated by the Pharmaceutical Research Institute at the headquarters of Renfu Pharmaceutical Group. The Group’s Pharmaceutical Research Institute is responsible for pharmaceutical research, human bioequivalence studies, and regulatory submissions. Our company is the marketing authorization holder.
The approval of this Abidor Hydrochloride Tablet further enriches the company’s antiviral product portfolio, providing patients with more treatment options.
Abidor Hydrochloride
Trending News
Corporate culture
Make drug launches safer and faster, and ensure the tree of life remains evergreen.
Learn more